Resources and programs for the cancer community are now easier to find and access in Southern Virginia thanks to the new Cancer Resource Center of Southern Virginia in Lawrenceville. The purpose of the Resource Center is to facilitate the availability of local, state and national cancer programs and resources to individuals living within the southern regions of the state. It will identify the specific needs and services that are of the greatest help to area residents affected by cancer through the guidance of a Cancer Task Force that it plans to develop with local cancer care providers, cancer community organizations, health district leaders and Saint Paul’s College.
VCU Massey Cancer Center postdoctoral scholar Upneet Kaur Sokhi, Ph.D., recently presented her research findings at the 41st John C. Forbes Graduate Student Research Colloquium. She was one of nearly a dozen Virginia Commonwealth University School of Medicine graduate students and postdoctoral scholars to present their research, which ranged from cancer to the neuronal control of appetite.
Internationally renowned VCU Massey Cancer Center researcher Sarah Spiegel, Ph.D., together with Santiago Lima, Ph.D., have co-authored an article for the Previews section of the Cell Press journal, Structure, on a recent research breakthrough. In their expert commentary, Spiegel and Lima discuss how the newly discovered atomic structure of sphingosine-1-phosphate will expand mechanistic understanding of the molecule significantly. The molecule itself was originally discovered by Spiegel in the mid-1990s and has been found to play a role in cancer progression, inflammation and cardiovascular disease.
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researcher Paul B. Fisher, M.Ph., Ph.D., has been awarded the Prostate Cancer Foundation’s 2012 A. David Mazzone PCF Challenge Award. Fisher shares this award with Drs. Martin G. Pomper and George Sgouros, both from Johns Hopkins University Medical Center. The Challenge Awards are highly competitive, two-year awards that provide a total of $1 million per team in support of large-scale innovative research projects in the area of prostate cancer. The award will provide VCU $400,000 in direct costs over two years.
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy. Recently published in the journal Clinical Cancer Research, the study provides the first preclinical evidence demonstrating that an ATM kinase inhibitor radiosensitizes gliomas.